Monash IVF Group Limited (ASX:MVF)
0.7150
-0.0200 (-2.72%)
Oct 17, 2025, 4:10 PM AEST
Monash IVF Group Revenue
In the fiscal year ending June 30, 2025, Monash IVF Group had annual revenue of 271.92 million AUD with 6.54% growth. Monash IVF Group had revenue of 131.53 million in the half year ending June 30, 2025, with 19.06% growth.
Revenue
271.92M
Revenue Growth
+6.54%
P/S Ratio
1.02
Revenue / Employee
304.84K
Employees
892
Market Cap
278.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 271.92M | 16.69M | 6.54% |
Jun 30, 2024 | 255.23M | 41.43M | 19.38% |
Jun 30, 2023 | 213.80M | 21.50M | 11.18% |
Jun 30, 2022 | 192.29M | 8.69M | 4.73% |
Jun 30, 2021 | 183.61M | 38.19M | 26.26% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Ramsay Health Care | 17.79B |
Sonic Healthcare | 9.65B |
Ansell | 3.06B |
Cochlear | 2.34B |
Regis Healthcare | 1.16B |
Telix Pharmaceuticals | 1.01B |
Neuren Pharmaceuticals | 218.86M |